2023 annual financial data
C4 Therapeutics 2023 Net margin
C4 Therapeutics 2023 net margin with verified reported values.
Direct answer
Net margin was -638.34%.
Operating income was -139,031,000 USD and net income was -132,493,000 USD.
Operating cash flow was -106,838,000 USD.
Get free C4 Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,756,000 USD
- Operating income
- -139,031,000 USD
- Net income
- -132,493,000 USD
- Operating cash flow
- -106,838,000 USD